Cosmos Health boosts Ethereum investment to $1.8M under $300M digital asset plan.
CEO Greg Siokas says firm remains committed to accelerating crypto acquisitions.
Stock up 200% in six months as Cosmos expands in healthcare and digital finance.
Cosmos Health Inc. (NASDAQ: COSM) has strengthened its position in digital assets with a fresh $300,000 purchase of Ethereum (ETH), bringing the healthcare group’s total investment in the cryptocurrency to $1.8 million.
The move, announced Monday, forms part of the company’s broader $300 million digital assets facility aimed at portfolio diversification and long-term growth.
The Chicago-based company, which operates across pharmaceutical manufacturing, distribution, and telehealth, has been increasingly active in the digital asset space over recent months.
Cosmos Health’s stock has surged nearly 200% over the past six months.
Strategic expansion through digital assets
Cosmos Health’s latest Ethereum acquisition underscores its commitment to integrating digital assets into its broader financial strategy.
“We have continued to increase our Ethereum holdings following last week’s purchase, bringing our total investment in ETH to $1.8 million,” said Chief Executive Officer Greg Siokas.
“We remain committed to accelerating our acquisition program under our $300 million financing facility,” he added, highlighting the company’s intention to expand its exposure to blockchain-based assets.
The purchase follows a series of previous cryptocurrency investments made under the same program, which was first announced earlier this year.
The initiative reflects Cosmos Health’s diversification approach — balancing its core healthcare operations with emerging opportunities in digital finance and technology.
Founded in 2009 and incorporated in Nevada, Cosmos Health operates across several key healthcare sectors, including nutraceuticals, branded pharmaceuticals, and healthcare distribution.
Its operations span Greece and the UK, with major distribution centers located in Thessaloniki, Athens, and Harlow.
Broader strategic developments
Beyond digital assets, Cosmos Health has been actively pursuing corporate and operational initiatives to expand its global footprint.
The company recently announced the appointment of Theodoros C. Karkantzos to its board of directors.
Karkantzos brings over 15 years of experience in investment and business development and will serve on the Nominating and Corporate Governance Committee.
Additionally, Cosmos Health expanded its Sky Premium Life brand into Kuwait through an exclusive distribution agreement with Diyar United.
Under the deal, Diyar United will market and distribute the company’s nutraceutical products across the Kuwaiti market, further strengthening Cosmos Health’s international presence.
At its most recent annual shareholder meeting, the company also secured approval to increase its authorized shares to 1.5 billion common shares and 300 million preferred shares, a move intended to provide greater financial flexibility.
A diversified path forward
Cosmos Health’s growing engagement with digital assets — particularly Ethereum — highlights a trend of traditional companies exploring blockchain integration and crypto investments as part of their financial diversification strategies.
While the company’s core focus remains in healthcare and wellness, its foray into digital assets and partnerships suggests a forward-looking approach toward technology-driven financial management.
With its Ethereum investment now totaling $1.8 million and a $300 million facility available for further expansion, Cosmos Health appears positioned to continue balancing innovation in both healthcare and financial markets as it seeks sustainable long-term growth.
